Navigation Links
RNs at Nine Catholic Healthcare West Hospitals Reach Agreement on New Master Pact
Date:9/5/2007

3,500 Nurses Fight Healthcare Takeaways, Win Better Patient Safety

Protections and Pay

10,000 CHW RNs in 25 Facilities Set to Bargain Together in 2009

OAKLAND, Calif., Sept. 5 /PRNewswire/ -- Some 3,500 registered nurses at nine Southern California and Central Coast facilities in the Catholic Healthcare West chain won sweeping improvements in a major contract settlement, the California Nurses Association announced today.

The agreement, which Rose Ann DeMoro, executive director of the California Nurses Association/National Nurses Organizing Committee, called "a significant advance for the retention and recruitment of registered nurses," will be voted on in membership meetings Thursday. Highlights of the contract, which include provisions protecting patient safety and healthcare benefits for current and retiree nurses, will help set new industry-wide standards for the treatment of nurses, and will set the stage for a new all-California contract to be negotiated in 2009 that will cover all 10,000 CHW RNs at 25 CNA-represented facilities.

"The nurses believe their voice was heard with an agreement that will increase patient safety and protect nurses," added DeMoro. "This agreement will certainly allow for the retention of experienced nurses and the recruitment of new nurses, while setting the stage for a statewide contract covering 10,000 RNs in 2009."

Key provisions of the agreement, first announced last week, include:

-- Incorporation of the state's mandated numeric RN-to-patient ratios to

protect patient safety with arbitration on any disputes involving

ratios, and inclusion of new ratios in certain units

-- No takeaways in healthcare, after picketing and collective action by

thousands of CHW nurses

-- Enhanced retirement security with a major improvement in retiree health

benefits, and an oversight committee of RNs selected by nurses and'/>"/>

SOURCE California Nurses Association
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Catholic Church and Abortion.
2. Catholics Should Halt Amnesty Support Over Abortion Issue: Vatican
3. Australian Catholics Rebel Over Stem Cell Vote Warning
4. Healthcare sector is now a multi billion-dollar industry in India
5. Iodex goes to SmithKline Beecham consumer Healthcare
6. Healthcare Professionals Might Want To Rethink Their Dress Code
7. WHO report asks for improved healthcare for mother and child
8. New X-ray machine launched by GE Healthcare
9. India To March Ahead in The Global HealthCare Competition
10. Medical Fraternity Urged To Revamp Indian Healthcare
11. British Healthcare Mission Explores Partnership Possibilities With Indian Healthcare Sector
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2008)...ocs determine who would benefit most from chemo af...16 (HealthDay News) -- A panel of 15 genes may hel...all cell lung cancer will experience a recurrence ..., a new study shows. , By extension, the same ...less aggressive forms of the cancer who would be a...
(Date:5/16/2008)...ON, May 16 /PRNewswire-USNewswire/ -- As tropical ... Irrawaddy delta, survivors of,Cyclone Nargis are ...Many,survivors still need assistance, as exposure ...an increasingly dire situation., "The people livi...recover from this disaster and get back on their f...
(Date:5/16/2008)... Funding Per Death Drops More in 2007, WASHINGTON...cer causes,one in three cancer deaths, the Nationa...its $4.8 billion budget in lung cancer research in...ung Cancer Alliance (LCA) today., The two other f...rograms -- Centers for Disease Control and Prevent...
(Date:5/16/2008)...O, May 16 /PRNewswire-FirstCall/ -- CryoCor, Inc. ...n the treatment of cardiac,arrhythmias, announced ...CryoCor common stock filed a complaint in the Supe...an Diego, naming as defendants each member of the,...Scientific Corporation.,The complaint is styled Se...
Breaking Medicine News(10 mins):Health News:Gene Signature May Predict Recurrence of Lung Cancer 2Health News:Gene Signature May Predict Recurrence of Lung Cancer 3Health News:Myanmar Cyclone Survivors Face New Challenges 2Health News:Lung Cancer Still Lowest in Federal Funding 2Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 2Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 3Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 4
...have lasted for less than three months. A new stud...oup classes, exercise sheet// handouts, and teleph...manage their back pain. Researchers from Indiana ... program for poor, urban patients with low back pa...
... Cedars-Sinai Medical Center in Los Angeles has be...cancer. While his research moves forward, he’s he...research involves an effective brain tumor vaccine...ide proteins on the tumor cell surface that the im...
...eir search for a cure for diabetes. A new study do...evelop into insulin producing //pancreatic islet c...atients with diabetes. The latest research is a f...nt that cures advanced type 1 diabetes in mice. Th...
...ients is associated with an increased risk for a h...searchers say the benefit of the treatment outweig... Combination antiretroviral therapy substantially...patients at risk for AIDS. Before this therapy was...
Other Medicine News:Health News:New vaccine for brain cancer 2Health News:HIV Treatment Said to Increase Heart Attack Risk 2
(Date:5/15/2008)...d with a newly cleared device to identify the, li... are associated with complicatio...5 /- InfraReDx, Inc. today,announced ... Mich., have,successfully used its LipiScan(TM) Co...rdiac catheterization. This is the first patient i...
(Date:5/15/2008)...May 15 /- Ergonex Pharma today,announ...ation (FDA) has,granted orphan drug designation to... hypertension (PAH). Terguride is currently being ...urope., "The FDA,s grant of orphan drug designati... our development program by offering regulatory,c...
(Date:5/15/2008)...y 15 /- Tigris Pharmaceuticals,Inc. ...earch and,Development Agreement (CRADA) with the N...linical and preclinical development of AFP-464, an...P-464 is converted to,metabolites which bind coval...tosis., This is part of a four-year CRADA encompa...
(Date:5/15/2008)...ains for an Antiplatelet Therapy that, Combined, w...tion of Plavix/Iscover and Aspirin, According ... Mass., May 15 /- Decision Resources,...firms for pharmaceutical and,healthcare issues, fi...,improvement in patient compared to Sanofi-Aventis...
Breaking Medicine Technology:First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 2First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 3First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 4Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 3Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 2Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 3Up for Debate This Week 3A National Service Mental Health Coverage and Consumer Product Safety 13227 1Up for Debate This Week 3A National Service Mental Health Coverage and Consumer Product Safety 13227 2Up for Debate This Week 3A National Service Mental Health Coverage and Consumer Product Safety 13227 3Publication in Clinical Cancer Research Confirms Ability of Peregrines Bavituximab to Target Tumor Blood Vessels with Excellent Specificity 3645 1Publication in Clinical Cancer Research Confirms Ability of Peregrines Bavituximab to Target Tumor Blood Vessels with Excellent Specificity 3645 2Publication in Clinical Cancer Research Confirms Ability of Peregrines Bavituximab to Target Tumor Blood Vessels with Excellent Specificity 3645 3Publication in Clinical Cancer Research Confirms Ability of Peregrines Bavituximab to Target Tumor Blood Vessels with Excellent Specificity 3645 4Publication in Clinical Cancer Research Confirms Ability of Peregrines Bavituximab to Target Tumor Blood Vessels with Excellent Specificity 3645 5Gentiva 28R 29 Health Services Completes Acquisition of Major Home Health Provider in CON State of Mississippi 13224 1Gentiva 28R 29 Health Services Completes Acquisition of Major Home Health Provider in CON State of Mississippi 13224 2Gentiva 28R 29 Health Services Completes Acquisition of Major Home Health Provider in CON State of Mississippi 13224 3Prime Healthcare Services Enters Into Network Wide Contract With Aetna Health Plans 13222 1Prime Healthcare Services Enters Into Network Wide Contract With Aetna Health Plans 13222 2
...RNewswire-FirstCall/ -- According to,study results...Association annual meeting, iloperidone, an invest...e a favorable akathisia,profile. Akathisia -- a de...s as an inability to sit still -- is a frequent si...e is being studied by Vanda,Pharmaceuticals Inc. ,...
...(BUSINESS WIRE) -- MGI PHARMA, INC.,(NASDAQ:MOGN),...nd,acute care, today announced the presentation of...Aquavan(R) (fospropofol,disodium) Injection in pat...y efficacy endpoint results, as well as safety dat...n Washington, D.C. by,Lawrence B. Cohen, MD, Depar...
Other Medicine Technology:Antipsychotic Iloperidone Results Show Favorable Akathisia Profile 2Antipsychotic Iloperidone Results Show Favorable Akathisia Profile 3Antipsychotic Iloperidone Results Show Favorable Akathisia Profile 4Antipsychotic Iloperidone Results Show Favorable Akathisia Profile 5Aquavan (Fospropofol Disodium) Injection Data Presented at,Digestive Disease Week 2007 2Aquavan (Fospropofol Disodium) Injection Data Presented at,Digestive Disease Week 2007 3Aquavan (Fospropofol Disodium) Injection Data Presented at,Digestive Disease Week 2007 4Aquavan (Fospropofol Disodium) Injection Data Presented at,Digestive Disease Week 2007 5
Drug controls sera available in three levels for the control of accuracy and percision for up to 18 analytes
Sera available in three levels for the control of accuracy and precision for up to 31 analytes
Human based material available in two levels for thecontrol of percision for up to 10 analytes
Human based material available in two levels for the control of accuracy and precision for upto 23 analytes.
Medicine Products: